Autonomix Medical, Inc.
NASDAQTotal Valuation
Autonomix Medical, Inc. carries a market capitalization of 2.49M, placing it among publicly traded companies globally. Its enterprise value stands at -77,110.00, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 2.49M |
| Enterprise Value | -77,110.00 |
Share Statistics
Autonomix Medical, Inc. currently has 543,000.00 shares outstanding.
| Shares Outstanding | 543,000.00 |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
| PE Ratio | N/A |
| PS Ratio | N/A |
| PB Ratio | 1.07 |
| P/TBV Ratio | 1.07 |
| P/FCF Ratio | -0.19 |
| P/OCF Ratio | -0.19 |
Financial Position
Autonomix Medical, Inc. maintains a current ratio of 4.85, meaning it holds 4.8x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 4.85 |
| Quick Ratio | 4.23 |
| Debt / Equity | N/A |
| Debt / EBITDA | N/A |
| Interest Coverage | N/A |
Financial Efficiency
| Return on Equity (ROE) | -315.99 |
| Return on Assets (ROA) | -248.22 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Stock Price Statistics
Autonomix Medical, Inc.'s stock has declined approximately -81.31868% over the past 52 weeks. The 50-day moving average sits at 6.10, while the 200-day moving average is 9.10.
| Beta (5Y) | N/A |
| 52-Week Price Change | -81.31868% |
| 50-Day Moving Average | 6.10 |
| 200-Day Moving Average | 9.10 |
| Average Volume (20 Days) | N/A |
Income Statement
EBITDA reached -16.37M, while operating income came in at -16.38M.
| Revenue | N/A |
| Gross Profit | N/A |
| Operating Income | -16.38M |
| Pretax Income | -16.11M |
| Net Income | -16.11M |
| EBITDA | -16.37M |
| EBIT | -16.38M |
| Earnings Per Share (EPS) | -39.35 |
Balance Sheet
Total book value stands at 3.16M, with working capital of 3.15M providing operational flexibility.
| Cash & Cash Equivalents | 3.46M |
| Total Debt | N/A |
| Net Debt | -3.46M |
| Equity (Book Value) | 3.16M |
| Book Value Per Share | 5.82 |
| Working Capital | 3.15M |
Cash Flow
Autonomix Medical, Inc. produced -13.22M in operating cash flow over the past twelve months. After subtracting -10,000.00 in capital expenditures, free cash flow totaled -13.23M - equivalent to -32.33 per share.
| Operating Cash Flow | -13.22M |
| Capital Expenditures | -10,000.00 |
| Free Cash Flow | -13.23M |
| FCF Per Share | -32.33 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -239.53 |
| FCF Yield | -518.15 |
Stock Splits
Autonomix Medical, Inc.'s most recent stock split took place on June 24, 2026 with a 21:1 split ratio.
| Last Split Date | 6/24/2026 |
| Split Ratio | 21:1 |
Scores
Autonomix Medical, Inc. posts an Altman Z-Score of -34.72, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -34.72 |